메뉴 건너뛰기




Volumn 8, Issue 10, 2010, Pages 2318-2321

rFVIIa transported from the blood stream into tissues is functionally active

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; CALCIUM CHLORIDE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SODIUM CHLORIDE;

EID: 78649346395     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.04010.x     Document Type: Letter
Times cited : (11)

References (11)
  • 1
    • 0034758420 scopus 로고    scopus 로고
    • Effective prophylaxis with daily recombinant factor VIIa (rFVIIa-Novoseven) in a child with high titre inhibitors and a target joint
    • Saxon BR, Shanks D, Jory CB, Williams V. Effective prophylaxis with daily recombinant factor VIIa (rFVIIa-Novoseven) in a child with high titre inhibitors and a target joint. Thromb Haemost 2001; 86: 1126-7.
    • (2001) Thromb Haemost , vol.86 , pp. 1126-1127
    • Saxon, B.R.1    Shanks, D.2    Jory, C.B.3    Williams, V.4
  • 2
    • 19444375983 scopus 로고    scopus 로고
    • Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors
    • Young G, McDaniel M, Nugent DJ. Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors. Haemophilia 2005; 11: 203-7.
    • (2005) Haemophilia , vol.11 , pp. 203-207
    • Young, G.1    McDaniel, M.2    Nugent, D.J.3
  • 3
    • 51249100418 scopus 로고    scopus 로고
    • Prophylaxis with recombinant factor VIIa for the management of bleeding episodes during immune tolerance treatment in a boy with severe haemophilia A and high-response inhibitors
    • Blatny J, Kohlerova S, Zapletal O, Fiamoli V, Penka M, Smith O. Prophylaxis with recombinant factor VIIa for the management of bleeding episodes during immune tolerance treatment in a boy with severe haemophilia A and high-response inhibitors. Haemophilia 2008; 14: 1140-42.
    • (2008) Haemophilia , vol.14 , pp. 1140-1142
    • Blatny, J.1    Kohlerova, S.2    Zapletal, O.3    Fiamoli, V.4    Penka, M.5    Smith, O.6
  • 5
    • 2342649465 scopus 로고    scopus 로고
    • Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency
    • Tcheng WY, Donkin J, Konzal S, Wong WY. Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency. Haemophilia 2004; 10: 295-8.
    • (2004) Haemophilia , vol.10 , pp. 295-298
    • Tcheng, W.Y.1    Donkin, J.2    Konzal, S.3    Wong, W.Y.4
  • 7
    • 34548096392 scopus 로고    scopus 로고
    • Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors
    • Konkle BA, Ebbesen LS, Erhardtsen E, Bianco RP, Lissitchkov T, Rusen L, Serban MA. Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors. J Thromb Haemost 2007; 5: 1904-13.
    • (2007) J Thromb Haemost , vol.5 , pp. 1904-1913
    • Konkle, B.A.1    Ebbesen, L.S.2    Erhardtsen, E.3    Bianco, R.P.4    Lissitchkov, T.5    Rusen, L.6    Serban, M.A.7
  • 10
    • 0027402655 scopus 로고
    • Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation
    • Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-44.
    • (1993) Blood , vol.81 , pp. 734-744
    • Morrissey, J.H.1    Macik, B.G.2    Neuenschwander, P.F.3    Comp, P.C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.